West Declares Quarterly Dividend
West (NYSE: WST) declared a regular quarterly dividend of $0.22 per share on its common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
West (NYSE: WST) declared a regular quarterly dividend of $0.22 per share on its common stock.
The board declared the dividend on December 9, 2025; it is payable on February 4, 2026 to shareholders of record on January 28, 2026.
Positive
- Quarterly dividend of $0.22 per share declared
Negative
- None.
Details
News Market Reaction – WST
On Dec 10, the day this news came out, WST closed 0.33% above the previous close.
Data tracked by StockTitan Argus for the Dec 10 session.
Key Figures
- Quarterly dividend
- $0.22 per share
- Regular dividend declared on Dec 9, 2025 for common stock
- Payment date
- February 4, 2026
- Dividend payable to eligible shareholders
- Record date
- January 28, 2026
- Shareholders of record date for dividend eligibility
- Q2 2025 dividend
- $0.21 per share
- Previously approved second-quarter 2025 dividend
- Q1 2025 dividend
- $0.21 per share
- Previously declared first-quarter 2025 dividend
Historical Context
-
Launch of West Synchrony prefillable syringe system for biologics and vaccines.
-
Announcement of multiple November–December 2025 investor conference appearances.
-
Q3 2025 beat with higher net sales, EPS, and raised full-year guidance.
-
Scheduling of Q3 2025 results release and conference call details.
-
Planned participation in three major September 2025 healthcare conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-declares-quarterly-dividend-302637318.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.